IHH Healthcare Berhad (KLSE:IHH)
Malaysia · Delayed Price · Currency is MYR 8.30
-0.09 (-1.07%)
At close: Jul 24, 2026
IHH Healthcare Berhad Financials Overview
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 26,004 | 25,745 | 24,383 | 20,935 | 17,989 | 17,218 |
Revenue Growth | 5.19% | 5.59% | 16.47% | 16.38% | 4.48% | 28.45% |
Gross Profit Gross Profit Growth | 8,635 | 8,537 | 8,322 | 7,065 | 6,172 | 5,999 |
Operating Income Operating Income Growth | 3,874 | 3,816 | 3,830 | 4,150 | 2,777 | 3,128 |
Net Income Net Income Growth | 2,115 | 2,101 | 2,657 | 2,952 | 1,496 | 1,774 |
Earnings Per Share EPS Growth | 0.24 | 0.24 | 0.30 | 0.34 | 0.17 | 0.20 |
EPS Growth | -12.21% | -21.12% | -10.02% | 97.28% | -15.89% | 790.65% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Hospital and Healthcare - Singapore Hospital and Healthcare - Singapore Growth | 5,780 | 5,962 | 6,146 | 5,582 | 4,920 | 5,034 |
Hospital and Healthcare - Malaysia Hospital and Healthcare - Malaysia Growth | 4,910 | 4,832 | 4,162 | 3,692 | 3,081 | 2,728 |
Hospital and Healthcare - India Hospital and Healthcare - India Growth | 4,177 | 4,183 | 4,030 | 3,554 | 3,175 | 3,729 |
Hospital and Healthcare - Greater China Hospital and Healthcare - Greater China Growth | 1,598 | 1,620 | 1,530 | 1,307 | 998.38 | 876.89 |
Hospital and Healthcare - Turkey and Europe Hospital and Healthcare - Turkey and Europe Growth | 8,794 | 8,458 | 7,249 | 5,966 | 4,353 | 4,347 |
Labs Labs Growth | 1,696 | 1,739 | 1,779 | 1,665 | 1,667 | - |
Parkway Life Real Estate Investment Trust (Plife REIT) Parkway Life Real Estate Investment Trust (Plife REIT) Growth | 445 | 440 | 414 | 408 | 376.2 | 370.69 |
Others Others Growth | 2,540 | 1,358 | 1,113 | 1,498 | 1,544 | 3,959 |
Unallocated MFRS129 Unallocated MFRS129 Growth | -404 | -483 | 116 | -320 | - | - |
Eliminations Eliminations Growth | -3,532 | -2,364 | -2,156 | -2,472 | -2,389 | -4,173 |
Total Total Growth | 26,004 | 25,745 | 24,383 | 20,935 | 17,989 | 17,132 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,337 | 2,350 | 2,396 | 2,784 | 4,005 | 5,478 |
Total Debt Total Debt Growth | 15,160 | 15,546 | 14,782 | 10,060 | 10,834 | 10,874 |
Net Cash (Debt) Net Cash Growth | -12,823 | -13,196 | -12,386 | -7,276 | -6,829 | -5,396 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.45 | -1.49 | -1.41 | -0.83 | -0.78 | -0.61 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5,431 | 5,574 | 4,285 | 3,759 | 3,668 | 3,532 |
Capital Expenditures CapEx Growth | -3,255 | -3,446 | -3,129 | -1,871 | -1,668 | -1,027 |
Free Cash Flow Free Cash Flow Growth | 2,176 | 2,128 | 1,156 | 1,888 | 1,999 | 2,504 |
Free Cash Flow Growth | 87.59% | 84.08% | -38.77% | -5.56% | -20.17% | 59.46% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 33.21% | 33.16% | 34.13% | 33.75% | 34.31% | 34.84% |
Operating Margin | 14.90% | 14.82% | 15.71% | 19.82% | 15.44% | 18.17% |
Pretax Margin | 13.99% | 13.32% | 15.40% | 19.34% | 12.32% | 14.84% |
Profit Margin | 8.13% | 8.16% | 10.90% | 14.10% | 8.32% | 10.30% |
FCF Margin | 8.37% | 8.27% | 4.74% | 9.02% | 11.11% | 14.55% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.105 | 0.105 | 0.100 | 0.090 | 0.070 | 0.060 |
Dividend Per Share Growth | 5.00% | 5.00% | 11.11% | 28.57% | 16.67% | 50.00% |
Dividend Yield | 1.26% | 1.21% | 1.40% | 1.55% | 1.21% | 0.89% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 34.67 | 36.80 | 24.21 | 17.99 | 36.61 | 36.39 |
Forward PE | 30.50 | 32.48 | 31.36 | 30.38 | 30.39 | 41.33 |
P/FCF Ratio | 33.70 | 36.33 | 55.65 | 28.13 | 27.40 | 25.78 |
PS Ratio | 2.82 | 3.00 | 2.64 | 2.54 | 3.05 | 3.75 |